Literature DB >> 28847531

A storm in the niche: Iron, oxidative stress and haemopoiesis.

Federica Pilo1, Emanuele Angelucci2.   

Abstract

Iron, although essential, is harmful in high amounts. Oxidative stress as a result of excess reactive oxygen species (ROS) and a prooxidative/antioxidative imbalance between ROS production and elimination, play a key role in cellular damage. There is evidence to support the role of ROS in the pathogenesis of a range of diseases including the myelodysplastic syndromes (MDS) and leukaemia. Oxidative stress seems to affect the self-renewal, proliferation and differentiation of haematopoietic stem cells and impair cell growth. Three aspects of these defective haemopoietic mechanisms may be associated with the activities of ROS: clonal evolution, haematological improvement and recovery of haemopoiesis after haematopoietic stem cell transplantation (HSCT). This review aims to provide haematologists with an overview of results from in vitro and murine models and preliminary clinical evidence on the diagnostic, prognostic and therapeutic implications of the complex interactions between the haemopoietic niche, iron, oxidative stress and inadequate haemopoiesis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clonal evolution; Haematopoietic stem cells; Iron; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28847531     DOI: 10.1016/j.blre.2017.08.005

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  17 in total

Review 1.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Which lower risk myelodysplastic syndromes should be treated with allogeneic hematopoietic stem cell transplantation?

Authors:  Marie Robin; Pierre Fenaux
Journal:  Leukemia       Date:  2020-07-13       Impact factor: 11.528

Review 3.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Blood Adv       Date:  2018-11-27

4.  Is dynamic thiol/disulfide homeostasis associated with the prognosis of myelodysplastic syndrome?

Authors:  Ucar Mehmet Ali; Anıl Tombak; Simten Dagdas; Aydan Akdeniz; Funda Ceran; Salim Neselioglu; Ozcan Erel; Gulsum Ozet
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

Review 5.  The Role of Iron in Benign and Malignant Hematopoiesis.

Authors:  Sayantani Sinha; Joana Pereira-Reis; Amaliris Guerra; Stefano Rivella; Delfim Duarte
Journal:  Antioxid Redox Signal       Date:  2021-01-07       Impact factor: 7.468

Review 6.  Controversies on the Consequences of Iron Overload and Chelation in MDS.

Authors:  Francesca Vinchi; Saskia Hell; Uwe Platzbecker
Journal:  Hemasphere       Date:  2020-05-27

7.  Cell Viability in Normal Fibroblasts and Liver Cancer Cells After Treatment with Iron (III), Nickel (II), and their Mixture.

Authors:  Sylwia Terpiłowska; Dorota Siwicka-Gieroba; Andrzej Krzysztof Siwicki
Journal:  J Vet Res       Date:  2018-12-31       Impact factor: 1.744

8.  Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem/progenitor cells and in leukemia cells.

Authors:  Tiziana Tataranni; Carmela Mazzoccoli; Francesca Agriesti; Luciana De Luca; Ilaria Laurenzana; Vittorio Simeon; Vitalba Ruggieri; Consiglia Pacelli; Gerardo Della Sala; Pellegrino Musto; Nazzareno Capitanio; Claudia Piccoli
Journal:  Stem Cell Res Ther       Date:  2019-06-13       Impact factor: 6.832

9.  Cytotoxicity of Iron (III), Molybdenum (III), and their Mixtures in BALB/3T3 and HepG2 Cells.

Authors:  Sylwia Terpiłowska; Dorota Siwicka-Gieroba; Andrzej Krzysztof Siwicki
Journal:  J Vet Res       Date:  2018-12-31       Impact factor: 1.744

Review 10.  Congenital Hemolytic Anemias: Is There a Role for the Immune System?

Authors:  Anna Zaninoni; Elisa Fermo; Cristina Vercellati; Anna Paola Marcello; Wilma Barcellini; Paola Bianchi
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.